Business
Innovotech Announces Grant of Stock Options
(TheNewswire) Edmonton - TheNewswire - October 20, 2020 ....
About this update from Innovotech Inc.
[{"type":"text","content":"Innovotech Announces Grant of Stock Options\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Edmonton -\n \n \n TheNewswire -\n \n \n October 20, 2020\n \n \n .\nInnovotech Inc. (\"Innovotech\") (TSXV:IOT) wishes to\nannounce that, in accordance with the policies of the TSX Venture\nExchange, the board of directors has approved a grant of stock options\nto directors and officers of Innovotech to purchase an aggregate of\n295,000 common shares pursuant to its stock option plan. These\noptions have an exercise price of $0.21 per common share and expire on\nOctober 13, 2025.\n \n \n \n \n About Innovotech Inc.\n \n \n \n \n Innovotech is a Canadian biotechnology company owning\nproprietary intellectual property, conducting\n \n \n \n \n contract research, and owning and providing proprietary\ndevices for testing in multiple applications in\n \n \n \n \n microbiology.\n \n \n \n \n Alan Savage\n \n \n \n \n Director & CFO\n \n \n \n \n Innovotech Inc.\n \n \n \n \n 604-220-4935\n \n \n \n \n [email protected]\n \n \n \n \n This document may contain forward-looking statements\nthat are predictive in nature and subject to risks and\n \n \n \n \n uncertainties that cannot be predicted or quantified;\nconsequently, actual results may differ materially from past\n \n \n \n \n results and those expressed or implied by any\nforward-looking statements. Factors that could cause or contribute\nto\n \n \n \n \n such risks or uncertainties include, but are not\nlimited to: the regulatory environment including the difficulty\nof\n \n \n \n \n predicting regulatory outcomes; changes in the value of\nthe Canadian dollar; the Company's reliance on a small\n \n \n \n \n number of customers including government organizations;\nfluctuations in operating results; government policies or\n \n \n \n \n actions; progress and cost of clinical trials; reliance\non key strategic relationships; uncertainty related to\nintellectual\n \n \n \n \n property protection and potential costs associated with\nits defense; the Company's exposure to lawsuits and other\n \n \n \n \n matters beyond the control of management. Should known\nor unknown risks or uncertainties materialize, or should\n \n \n \n \n management's assumptions prove inaccurate, actual\nresults could vary materially from those anticipated. The\n \n \n \n \n Company undertakes no oblig...